Expert insights. Personalized for you.
Immune Response Related Topics 
Bio Pharma Dive
JUNE 8, 2022
The biotech claims study results could position its reformulated vaccine as a booster in the fall, though it’s unclear how well the shot can prevent sickness caused by omicron or newer strains of the variant
Bio Pharma Dive
OCTOBER 13, 2021
Results suggested Pfizer's and Moderna's vaccines may serve as a more potent booster for those who initially received Johnson & Johnson's shot, although data are limited and preliminary
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Scienmag
MARCH 17, 2022
Social & Behavioral Science brain coronavirus Huddersfield immune response scientists show triggers
Scienmag
JUNE 2, 2022
Fever, cough, sore throat – symptoms in the spotlight in the era of COVID-19 – are just some of the tell-tale signs of our body’s immune system kicking into action against an unwanted intruder. Whether triggered by an infection, an allergen, or a vaccine, immune responses are driven by a complex array of cellular processes […]. Latest News Decoding immune language responses
Bio Pharma Dive
OCTOBER 25, 2021
The trial results should allow the company to ask the FDA for approval of its vaccine in younger children, just as Pfizer nears a crucial decision for its shot in 5- to 11-year olds
Bio Pharma Dive
SEPTEMBER 20, 2021
The results position Pfizer and BioNTech to seek clearance in children as young as five years old. But the companies haven't yet shared data on a rare heart inflammation associated with their shot that's a concern for regulators
Scienmag
APRIL 13, 2022
Research led by the University of Minnesota Medical School looked at if exposure to pathogens, in particular helminths, can stimulate the immune system and reduce predisposition for inflammatory […]. Biology immune parasitic research response worms
Scienmag
JUNE 15, 2022
Mathematics activity boost flu immune jab Metaanalysis Physical response review Systematic
Scienmag
OCTOBER 25, 2021
to downgrade its immune response. In severe COVID-19, however, this messenger is released at the very beginning of the infection, thus blocking the early control of the pathogen by the innate immune system.
Scienmag
JUNE 1, 2022
Cedars-Sinai investigators have identified a gene that plays an essential role in the innate human immune system. The gene, NLRP11, helps activate the inflammatory response that tells the body’s white blood cells to go on the attack against a foreign presence. Latest News CedarsSinai critical gene human immune investigators response
Scienmag
JUNE 21, 2022
Therefore, new therapeutic options such as targeted therapy that boosts antitumor immunity are needed to improve ovarian cancer treatment efficacy and patient survival. Biology approach identify immune reactivate response scientists therapeutic tumors Wistar
Pharma Phorum
MARCH 15, 2021
MeMed CEO Dr. Eran Eden explores the relationship between the host immune response and SARS-CoV-2 infection and how technology could help personalise treatment strategies. One of these involves listening to what the body’s own immune system can tell us.
|
BioTech 365
JUNE 24, 2022
New Data Highlight Immune Response to COVID-19 Vaccines in Individuals with Relapsing Forms of Multiple Sclerosis Treated with Zeposia (ozanimod) New Data Highlight Immune Response to COVID-19 Vaccines in Individuals with Relapsing Forms of Multiple Sclerosis Treated with Zeposia (ozanimod) … Continue reading → Business Wire
Scienmag
NOVEMBER 25, 2021
A new study aimed at explaining differential susceptibility to viral epidemics reveals that ancestry and associated genetic variation can explain population-level differences in the immune response to the flu virus and perhaps also to COVID-19. Latest News ancestry genetic immune influenza response shapes virus
Scienmag
DECEMBER 7, 2020
The addition of an anti-inflammatory medication to a common chemotherapy drug may improve immune response in patients by activating cells to fight cancer Credit: Cedars-Sinai LOS ANGELES (EMBARGOED UNTIL DEC.
Scienmag
JULY 20, 2021
— Mayo Clinic researchers have found that acute kidney injury associated with COVID-19 resembles sepsis-caused kidney injury, and the immune response triggered by the infection plays a pivotal role. ROCHESTER, Minn. The findings, published in Mayo Clinic Proceedings, also suggest that mitochondrial dysfunction — a loss of function in cellular energy production — is commonly […]. Infectious Emerging Diseases Infectious/Emerging Diseases Medicine/Health
Scienmag
JULY 12, 2021
Scientists have produced the first fine-detail molecular blueprints of a bacterial enzyme known as Lit, which is suspected to play a “stealthy” role in the progression of infection by reducing the immune response. Blueprints such as these allow drug designers to uncover potential weaknesses in bacterial arsenals as they seek to develop new therapeutics that […].
Scienmag
MARCH 10, 2021
Immune cells specialize to ensure the most efficient defense against viruses and other pathogens. Researchers at the University of Basel have shed light on this specialization of T cells and shown that it occurs differently in the context of an acute and a chronic infection. This could be relevant for new approaches against chronic viral […]. Biology Immunology/Allergies/Asthma Medicine/Health Molecular Biology Virology
Scienmag
APRIL 16, 2021
Credit: (C) Erica Tandori Researchers within the Biomedicine Discovery Institute at Monash University have made a breakthrough in understanding the role played by high-risk immune genes associated with the development of rheumatoid arthritis (RA).
BioTech 365
JUNE 13, 2022
Press Release: Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron Press Release: Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron Sanofi–GSK next-generation COVID-19 booster delivers strong immune response … Continue reading → GlobeNewswire
BioSpace
OCTOBER 6, 2021
The patch is not only painless, it requires less vaccine to generate the same or greater effects
Scienmag
MARCH 10, 2022
Technology and Engineering Bioengineered confirms evokes immune protective protein response RSV study vaccine
Scienmag
MARCH 10, 2022
As a result of this damage, the body mounts an inflammatory response in an attempt to heal the injury. Chemistry AND Physics awarded cardiac examine grant immune innate Lin NIH response Zhiqiang
The Pharma Data
OCTOBER 22, 2020
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, currently being evaluated in phase 3 global trials, delivers a strong immune response, according to a new UK study.
BioSpace
OCTOBER 25, 2020
FDA greenlit the restart of AstraZeneca’s Phase III COVID-19 vaccine trial, the company said the preventative medication boosts immune responses in older and younger adults against the novel coronavirus Days after the U.S.
BioSpace
JUNE 15, 2021
?The new data shows REGEN-COV reduced the risk of death in hospitalized patients unable to mount their own immune response by 20
Scienmag
SEPTEMBER 21, 2020
September 21, 2020–(BRONX, NY)–The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults.
BioTech 365
JANUARY 10, 2022
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV® test recently … Continue reading → GlobeNewswire
BioTech 365
JANUARY 10, 2022
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV® test recently … Continue reading → GlobeNewswire
BioTech 365
JANUARY 10, 2022
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV® test recently … Continue reading → GlobeNewswire
The Pharma Data
OCTOBER 26, 2020
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, elicited immune responses in older coronavirus patients similar to ones generated in younger adults, lending more promise to a vaccine that’s seen as one of the leading contenders in the race to become the first approved COVID-19 vaccine.
The Pharma Data
MAY 17, 2021
response in the over-50s, the age group deemed at higher risk for contracting the severe form of the virus. . The interim results from the phase 2 trial on the vaccine, published today, on the contrary, showed a “ strong neutralizing antibody response” ?
BioSpace
DECEMBER 10, 2020
The COVID-19 vaccine candidate developed by Sanofi and GlaxoSmithKline hit a snag that will delay the launch of a Phase III study due to an insufficient immune response in older trial patients
BioSpace
DECEMBER 2, 2021
IDRI is working with a newly-formed consortium to develop a next-gen COVID-19 vaccine that will be stable at routine temperatures and that may be able to confer immunity for a longer duration
Scienmag
JANUARY 14, 2021
14, 2021) – Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body’s immune response. HOUSTON – (Jan.
Scienmag
APRIL 1, 2021
Early life exposure to antibotics in utero and through mother’s milk disrupts beneficial gut bacteria, compromising T-cell development, Rutgers research shows Exposure to antibiotics in utero and infancy can lead to an irreversible loss of regulatory T-cells in the colon-a valuable component of the immune system’s response toward allergens in later life – after only […].
BioTech 365
MAY 4, 2022
Atreca Announces Publication in PNAS: “Mobilization of Innate and Adaptive Antitumor Immune Responses by the RNP-Targeting Antibody ATRC-101” Atreca Announces Publication in PNAS: “Mobilization of Innate and Adaptive Antitumor Immune Responses by the RNP-Targeting Antibody ATRC-101” SAN CARLOS, Calif.,
Scienmag
OCTOBER 12, 2021
A quick stick in the arm with an approved COVID-19 vaccine elicits a flurry of activity in the body’s immune system. Biology COVID19 immune infection prior response vaccine
BioSpace
NOVEMBER 1, 2020
Newly announced results of a Phase I dose-escalation study show CureVac’s COVID-19 vaccine candidate, CVnCoV, generates noticeable immune responses in healthy volunteers
236 
Let's personalize your content